We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
-12.72%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$94M
AUM Growth
-$25.2M
(-21%)
Cap. Flow
-$6.81M
Cap. Flow
% of AUM
-7.25%
Top 10 Holdings %
Top 10 Hldgs %
39.65%
Holding
76
New
5
Increased
32
Reduced
9
Closed
7
Top Buys
| 1 |
Radiant Logistics
RLGT
|
+$1.19M |
| 2 |
Rigel Pharmaceuticals
RIGL
|
+$1.05M |
| 3 |
Fidelity National Financial
FNF
|
+$1.02M |
| 4 |
Warner Bros
WBD
|
+$927K |
| 5 |
Clear Secure
YOU
|
+$675K |
Top Sells
| 1 |
Cytokinetics
CYTK
|
+$4.83M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$2.61M |
| 3 |
Intel
INTC
|
+$2.48M |
| 4 |
B
Barrick Mining
B
|
+$2.39M |
| 5 |
Theravance Biopharma
TBPH
|
+$1.15M |
Sector Composition
| 1 | Healthcare | 38.57% |
| 2 | Energy | 12.07% |
| 3 | Financials | 12.06% |
| 4 | Industrials | 8.35% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARKOW
51
DELISTED
ARKO Corp Warrant
ARKOW
| $568K | 0.6% |
400,000
| – | – |
|
52
Heron Therapeutics
HRTX
$83.1M
| $558K | 0.59% |
200,000
| – | – |
|
53
Eledon Pharmaceuticals
ELDN
$310M
| $549K | 0.58% |
225,000
| – | – |
|
|
SVC
54
Service Properties Trust
SVC
$1.11B
| $523K | 0.56% |
20,000
+10,000
| +100% | +$345K |
|
|
55
Clear Secure
YOU
$5.51B
| $500K | 0.53% |
+25,000
| New | +$675K |
|
56
BioCardia
BCDA
$13M
| $477K | 0.51% |
21,933
| – | – |
|
57
Nektar Therapeutics
NKTR
$2.31B
| $475K | 0.51% |
8,333
+3,333
| +67% | +$210K |
|
|
SPPI
58
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $468K | 0.5% |
600,000
| – | – |
|
59
Gain Therapeutics
GANX
$71.7M
| $450K | 0.48% |
125,000
| – | – |
|
60
Smith Micro Software
SMSI
$14.5M
| $432K | 0.46% |
4,375
+375
| +9% | +$43.6K |
|
|
BCEL
61
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $403K | 0.43% |
225,000
+75,000
| +50% | +$157K |
|
|
NBSE
62
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $389K | 0.41% |
18,500
+2,250
| +14% | +$52.8K |
|
63
inTEST
INTT
$184M
| $375K | 0.4% |
55,000
| – | – |
|
64
Amneal Pharmaceuticals
AMRX
$5.49B
| $318K | 0.34% |
+100,000
| New | +$362K |
|
65
Vornado Realty Trust
VNO
$7.5B
| $286K | 0.3% |
+10,000
| New | +$357K |
|
66
Lantern Pharma
LTRN
$39.6M
| $258K | 0.27% |
45,100
+11,335
| +34% | +$67.6K |
|
67
Pan American Silver
PAAS
$18.4B
| $197K | 0.21% |
10,000
-20,000
| -67% | -$479K |
|
|
B
68
Barrick Mining
B
$60.2B
| $177K | 0.19% |
10,000
-110,000
| -92% | -$2.39M |
|
69
Compass Therapeutics
CMPX
$385M
| $80K | 0.09% |
30,000
-270,000
| -90% | -$586K |
|
70
Aterian
ATER
$14M
| – | – |
-8,333
| Closed | -$243K |
|
71
Garrett Motion
GTX
$5.96B
| – | – |
-90,000
| Closed | -$647K |
|
|
72
Intel
INTC
$518B
| – | – |
-50,000
| Closed | -$2.48M |
|
73
Newell Brands
NWL
$2.19B
| – | – |
-20,000
| Closed | -$428K |
|
74
Relmada Therapeutics
RLMD
$652M
| – | – |
-15,000
| Closed | -$405K |
|
|
75
Theravance Biopharma
TBPH
$877M
| – | – |
-120,000
| Closed | -$1.15M |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM